Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

AbbVie (prior sponsor, Abbott) · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
secondary hyperparathyroidism, chronic kidney disease stage v, cardiac morbidity, secondary hyperparathyroidism (shpt), paricalcitol, chronic kidney disease stage 5 (ckd stage 5), observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861372
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.